Welcome to our dedicated page for Marex Group SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Marex Group's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Marex Group's regulatory disclosures and financial reporting.
Marex Group plc is offering Autocallable Contingent Income Barrier Notes linked to the worst performing of the S&P 500, Russell 2000 and Nasdaq-100. The notes have a $1,000 principal amount per note, may pay a quarterly contingent coupon (at least 2.75% per quarter; 11.00% per annum), are callable if each underlying is at or above 100% of its initial value on a Call Observation Date, and mature on June 1, 2029 (Final Valuation Date: May 29, 2029). If the Worst Performing Underlying’s Reference Return is below -30.00% at maturity, investors suffer full downside exposure and may lose up to 100% of principal; Coupons are paid only when each underlying is at or above 70.00% of its initial value on the relevant determination dates. Estimated initial value on the Pricing Date is expected between $950.00 and $990.00 per note.
Marex Group plc is offering Contingent Income Barrier Notes linked to the worst performing of DIA, QQQ and SPY, with a $1,000 principal per note and an expected term of approximately three years to May 24, 2029. Monthly contingent coupons will be payable at a rate of at least 0.758% per month (approximately 9.10% per annum) if each underlying closes at or above 70.00% of its initial value on the coupon determination date. If the worst performing underlying declines by more than 30.00% at final valuation, principal is exposed to loss on a 1:1 basis. The Estimated Initial Value is expected to be between $955.00 and $995.00 per note and will be set on the Trade Date.
MRX reported proposed resale of 15,999 shares of Common Stock via a Form 144 filing. The filing lists recent dispositions by Thomas Texier: 14,427 shares sold on 02/02/2026 ($567,398.04), 03/02/2026 ($633,750.70), and 04/01/2026 ($627,715.88). The securities to be sold were acquired in a private transaction on 02/26/2021.
Marex Group plc is offering $8,500,000 of Issuer Callable Contingent Income Barrier Notes linked to the worst performing of the iShares MSCI EAFE ETF, the Russell 2000 and the Nasdaq-100. The Notes pay a quarterly Contingent Coupon of $34.75 per $1,000 (3.475% per quarter; 13.90% per annum) only if each underlying meets its Coupon Trigger on scheduled Coupon Determination Dates. The Notes mature on January 27, 2028 (Final Valuation Date January 24, 2028) and are issuer‑callable on specified quarterly Call Payment Dates beginning July 28, 2026. At maturity you may receive the Principal plus final Contingent Coupon, the Principal only, or suffer up to 100% principal loss if the Worst Performing Underlying falls below its Barrier Value.
Marex Group plc is offering Issuer Callable Contingent Income Barrier Notes linked to the worst performing of the EFA, RTY and NDX. The Notes have a $1,000 Principal Amount per Note, a Trade Date of April 24, 2026, an Original Issue Date of April 29, 2026, a Final Valuation Date of January 24, 2028 and a Maturity Date of January 27, 2028.
The Notes pay a quarterly Contingent Coupon of $34.75 per $1,000 (3.475% per quarter; 13.90% per annum) only if each Underlying is at or above its Coupon Trigger on the applicable Coupon Determination Date; otherwise no coupon is paid. The Coupon Trigger equals 70% of the Initial Value and the Barrier Value equals 65% of the Initial Value. Payment at maturity depends on the Reference Return of the Worst Performing Underlying with principal fully at risk if the Final Value is below the Barrier Value.
Marex Group plc President Simon Van Den Born reported selling a total of 13,265 Ordinary Shares on April 20, 2026 in two open-market transactions. One sale covered 12,624 shares at a weighted average price of $50.9165 per share, and the other covered 641 shares at a weighted average price of $51.7098 per share.
The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan that he entered into on December 12, 2025. After these sales, each line item shows he continued to hold more than 1.5 million Ordinary Shares directly. His reported holdings include 383,741 shares underlying deferred bonus plan awards, each representing a contingent right to receive one Ordinary Share upon vesting and settlement.
Marex Group plc has issued $500,000,000 of 5.680% Senior Notes due 2031 in a completed public debt offering. The notes are senior unsecured obligations paying 5.680% interest in cash each April 21 and October 21, starting October 21, 2026, and maturing on April 21, 2031.
The company plans to use the net proceeds for working capital, to fund incremental growth and for other general corporate purposes. Marex may redeem the notes early at a make-whole price before March 21, 2031, or at 100% of principal plus accrued interest on or after that date. Holders can require a 101% repurchase plus accrued interest if a Change of Control Triggering Event occurs, and a future Bermuda holding company is expected to assume the notes as part of a proposed group reorganization.
Marex Group plc is offering $500,000,000 aggregate principal amount of 5.680% Senior Notes due April 21, 2031. The Notes pay interest semi-annually beginning October 21, 2026, and are a new issue for which Marex expects net proceeds to the issuer of approximately $498.0 million. Interest rates may adjust up or down based on credit rating changes by S&P and Fitch, and holders have a repurchase right at 101% of principal following a defined Change of Control Triggering Event. Marex may redeem the Notes in specified circumstances, including a Make-Whole Redemption, Par Call Redemption, Clean-up Call or upon certain tax changes. Marex also discloses a proposed redomiciliation to Bermuda, under which a new Bermuda parent would be expected to assume and be substituted as issuer of the Notes. Marex provided preliminary Q1 2026 ranges: revenue $667M–$697M and estimated profit after tax from continuing operations $103M–$111M.
Marex Group plc proposes an offering of senior notes due 2031 and files a preliminary prospectus supplement that also discloses recent corporate actions and preliminary Q1 2026 results. The supplement details a proposed redomiciliation to Bermuda, planned assumption of the notes by the new Bermuda parent, and preliminary unaudited Q1 2026 financial ranges.
The excerpt shows a $0.15 per-share dividend paid March 31, 2026; 71,930,870 ordinary shares outstanding as of the date of the supplement; and preliminary Q1 2026 estimated revenue of $667M–$697M with estimated adjusted profit before tax of $140M–$150M. The offering amount and interest rate are placeholder text in this excerpt.
Marex Group plc officer Paolo Tonucci reported selling 16,666 Ordinary Shares of the company on April 13, 2026 in open-market transactions. The sales occurred in three blocks of 6,760, 5,829 and 4,077 shares at weighted average prices of $50.6012, $51.5564 and $52.3578, respectively. These transactions were executed under a pre-arranged Rule 10b5-1 trading plan entered into on October 22, 2025, indicating they were scheduled in advance. Following the sales, Tonucci directly holds 1,363,357 Ordinary Shares, which include 286,871 shares underlying deferred bonus plan awards that each convert into one Ordinary Share upon vesting and settlement.